-
Published17/04/2019
-
Deadline28/02/2021
-
Today11/08/2026
Utilities
- indicates text translated automatically in your browsing language
Germany-Dortmund: Pharmaceutical products
The subject of this publication is the conclusion of contracts under § 130a(8) SGB V for the active substances metformin & Sitagliptin (ATC A10BD07), Sitagliptin (ATC A10BH01), erythropoietin (ATC B03XA01), Valsartan & Amlodipine (ATC C09DB01), glatiramer (only medicinal products with the active substance 20 mg, ATC L03AX13), iotropium (excluding hard capsules with powder for inhalation, ATC R03BB04) in the context of an ‘open house’ procedure. Under standard contractual conditions and a uniform access procedure, all appropriate and interested pharmaceutical undertakings or groups of pharmaceutical undertakings shall be offered the conclusion of a discount agreement pursuant to Paragraph 130a(8) of the SGB V for those active ingredients.
The earliest contract start date is 01/06/2019. On this basis, the maximum duration of the contract will be 24 months.
Official name: AOK Nordwest – Die Gesundheitskasse
Postal address: Kopenhagener Str. 1
Town: Dortmund
NUTS code: DE
Postal code: 44269
Country: DEU
Contact person: Unternehmensbereich Ambulante Versorgung
Main address: www.aok.de
Framework agreement with several operators
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.